Harrison.ai nabs $112M for US expansion
Harrison.ai, a developer of healthcare diagnostic support tools, raised $112 million in a Series C funding round.
Australian-based investment firms Aware Super and ECP co-led the round. Other investors included venture capital firm Horizons Ventures and Australia’s National Reconstruction Fund Corporation, a public investor that supports the country’s industry and economy.
Related: Top digital health funding: Nutrition startups raise $50M each
The company sells artificial intelligence diagnostic tools for radiology and pathology to hospitals and health systems primarily in Australia. The round will support Harrison.ai’s expansion in the U.S., according to a news release.
Harrison.ai last raised $97 million in a Series B funding round in January 2022.
Candid Health raises $52.2M for RC
Candid Health, a revenue cycle management company, raised $52.2 million in a Series C funding round.
Venture capital firm Oak HC/FT led the round. Venture capital firms 8VC, First Round Capital, Y Combinator and Boxgroup participated.
The company sells a tool to providers that aims to automate their claims and billings processes. Candid Health will use the funding to invest in generative AI and scale with more customers, according to a news release.
This round brings the company's total raised to $99.5 million.
Prenuvo raises $120M
Prenuvo, a company that conducts preventative MRI scans, raised $120 million in a Series B funding round. Read more.
Epicore Biosystems closes $26M Series B
Epicore Biosystems, a wearables company, raised $26 million in a Series B funding round.
The Steele Foundation for Hope, a non-profit organization, was the sole participant and lead investor for the round.
The company has developed a wearable sensor which measures a user’s sweat composition and fluid losses non-invasively for hydration, stress and wellness. Epicore sells access to its wearables through enterprise subscription-based models. Funding will help Epicore scale and expand its product into new biomarkers focused on kidney and women’s health as well malnutrition and environmental toxin exposures, the company said in a news release.
The round brings Epicore's total raised to $37.4 million.
Keragon raises $7.5M seed round
Keragon, a healthcare automation technology company, closed a $7.5 million seed funding round.
Venture capital firm Upfront Ventures led the round. Existing investors Afore Capital, Focal and 25m Health also participated.
The company integrates with software tools like electronic health records, scheduling tools and referral management systems to automate processes such as patient intake and appointment scheduling. The company will use the round to develop AI agents for specific tasks, said Keragon CEO and co-founder Conno Christou in an interview.
Keragon, which launched in June 2024, has raised $10.5 million.
